Synairgen

(SNG)
Sector: Pharmaceuticals & Biotechnology
4.65p
0.02p 0.43
Last updated: 11:47:52

Share information

Name Synairgen
Epic SNG
Isin GB00B0381Z20
Index AIM100 AIM350
Industry Pharmaceuticals & Biotechnology

Key numbers

Latest share price 4.65p Net gearing n/a
Market capitalisation £9.42 Debt ratio n/a
Shares in issue 201.37 Debt-to-equity ratio n/a
P/E ratio n/a Assets / equity ratio n/a
Total dividends per share n/a Price to book value n/a
Dividend yield n/a ROCE -100.34
Dividend cover n/a EPS growth n/a
Earning per share -8.76 52-week high / low 3.40p / 9.80p

Dividends

Type Ex-date Pay-date Net-dividend
No dividends declared

Contact details

Company name Synairgen
Address Mailpoint 810, Southampton General Hospital, Tremona Road, Southampton, United Kingdom, SO16 6YD
Telephone 44 (0) 23 8051 2800
Website http://www.synairgen.com

Directors

Director Position
Mr Richard J Marsden CEO
Dr Felicity Gabbay Non-Executive Director
Mr Simon J B Shaw Non-Executive Chairman
Mr Bruce Campbell Independent Non-Executive Director
Prof. Stephen T Holgate Independent Non-Executive Director
Ms Amanda Radford Independent Non-Executive Director
Mr Phillip David Monk Chief Scientific Officer
Mr Joseph Colliver CFO & Executive Director

Company financials

Assets £ (m) 2022 2021 2020
Reporting date 31/12/22 31/12/21 31/12/20
Intangible asssets and goodwill 0.04 0.05 0.04
Investments and other non-current assets n/a n/a n/a
Total non-current assets 0.13 0.23 0.39
Inventory / work in progress n/a n/a 0.04
Trade and other receivables 3.72 10.59 9.37
Cash and equivalents 15.93 33.83 74.98
Other current assets and asset held for resale 3.75 n/a 3.77
Total of all assets 23.53 44.64 88.55
Liabilities £ (m) 2022 2021 2020
Short term liabilities 3.25 7.64 3.41
Long term liabilities n/a n/a n/a
Other liabilites / pension etc n/a n/a n/a
Total of all liabilities 3.25 7.64 3.41
Net assets £ (m) 2022 2021 2020
Net assets 20.27 37 85.14
Equity £ (m) 2022 2021 2020
Share capital 2.01 2.01 2
Minority interests n/a n/a n/a
Retained earnings -107.47 -90.74 -42.59
Share premium account 125.25 125.25 125.25
Total equity 20.27 37 85.14
Income £ (m) 2022 2021 2020
Turnover n/a n/a n/a
Operating profit -20.3 -57.87 -17.74
Pre-tax profit -20.09 -57.86 -17.73